B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

ABCC9

MOLECULAR TARGET

ATP binding cassette subfamily C member 9

UniProt: O60706NCBI Gene: 100602 compounds

ABCC9 (ATP binding cassette subfamily C member 9) is targeted by 2 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting ABCC9

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Cromakalim2.4811
2Glyburide1.102

About ABCC9 as a Drug Target

ABCC9 (ATP binding cassette subfamily C member 9) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 2 compounds with documented ABCC9 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

ABCC9 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.